FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website
horizonal rule
Dockets Management

Back



1995S-0316
RPT 266
Volumes 195-197

Cover Page, Correspondence, and New Dietary Ingredient Notification for Kaneka QH

References

Aberg, F.; Appelkvist, E.L.; Dallner, G,; Ernster, L. 1992. Distribution and redox state of ubiquinones in rat and human tissues. Arch Biochem Biophys 295: 230-234. Cited In: Podda et al., 1996. Published Material

Arroyo, A.; Kagan, V.E.; Tyurin, V.A.; Burgess, J.R.; de Cabo, R.; Navas, P. 2000. NADH and NADPH-dependent reduction of coenzyme Q at the plasma membrane. Antioxidants & Redox Signaling 2 (2): 251-262. Published Material

Baggio, E.; Gandini, R.; Plancher, A.C.; Passeri, M.; Carmosino, G. 1994. Italian mulitcenter study on the safety and efficacy of coenzyme Q10 as adjunctiie therapy in heart failure. Molec. Aspects Med. 15 (Supplement): S287-S294. Published Material

Battino, M.; Fen-i, E.; Gorini, A.; Villa, R.F.; Huertas, J.F.R.; Fioreilla, P.; Genova, M.L.; Lenaz, G.; Marchetti, M. 1992. Natural distribution and occurrence of coenzyme Q homologues. Membrane Biochemistry 9: 179-190. Published Material

Bertelli, A.; and Runca, G. 1990. Carnitine and coenzyme Q10: biochemical properties and functions, synergism and complenentary action. Int J Tissue React 12 (3): 183-186. Published Material

Budavari, S.; O’Neil, M.J.; Smith, A.; Heckelman, P.E.; Kinneary, J.F. (Eds.). 1996. The Merck Index. An Encyclopedia of Chemicals, Drugs and Biologicals. Twelfth Edition. Merck & Co., Inc., New Jersey, p. 1679. Published Material

Chiba, T.; Watanabe, T.; Kume, Y.; Sugiyama, K.; Shiojirl, H. 1972a. Toxicological studies of ubiquinone-10 (I) Acute toxicity test in rats and mice and subacute and chronic toxicity tests in rats. Oyo Yakuri 6: 769-779. Abstract in English, Also cited in Folkers and Morishita, 1987. Published Material

Chiba, T.; Sugiyama, K.; Kume, Y.; Shiojiri, H.; Watanabe, T.; Ozeki, M, 1972b. Toxicological studies of ubiquinone-IO (II) Subacute toxicity test in rabbits. Oyo Yakuri 6:781-786. Abstract in English. Also cited in Folkers and Morishita, 1987. Published Material

Crane, F.L.; Sun, 1.L.; Sun, E.E. 1993. The essential functions of coenzyme Q. Clin Investig 71: S55-S59. Cited In: Kontush et al., 1999. Published Material

Czerniak, R. 2001. Gender-based differences in pharmacokinetics in laboratary animal models. Int J Toxicol 20 (3): 161-163. Published Material

Edlund, P.O. 1988. Determination of coenzyme Q10, a-tocopherol and cholesterol in biological samples by coupled-column liquid chromatography with coulometric and ultraviolet detection. J Chromatogr 425: 87. Cited In: Kontush et al., 1997. Published Material

Emster, L.; and Datlner, G. 1995. Biochemical, physiological and medical aspects of ubiquinone function. Biochimica et Biophysics Acta 1271: 195-204. Published Material

Ernster, L.; and Forsmark-Andree, P. 1993. Ubiquinol: An endogenous antioxidant in aerobic organisms. Clin Invest 71: S60. Cited In: Kontush et al., 1997. Published Material

Folkers, K.; and Moriihita, M. 1987. Critique of the metabolism, pharmacokinetics, and toxicology of Coenzyme Q10. Chemiker-Zeitung 111 (4): 139-143. Published Material

Forsmark-Andree, P.; Lee, C.-P.; Daltner, G.; Ernster, L. 1997. Lipid peroxidation and changes in the ubiquinone content and the respiratory chain enzymes of submitochondrial particles. Free Radic Biol Med 22: 391-400. Cited In: Ibrahim et al., 2000. Published Material

Frei B.; Kim, M.C.; Ames, B.N. 1990. Ubiquinol-10 is an effective fipid-soluble antioxidant at physiological concentrations. Proc Watt Acad Sci 87: 4879-4883. Published Material

Hofman-Bang, C.; Rehnquist, N.; Swedberg, K., et al. 1995. Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart faiiure. J Cardiac Failure 1: 101-107. Cited In: Tran et al., 2001. Published Material

Hughes, K.; Lee, B-L.;, Feng, X.; Lee, J.; Ong, C.N. 2002. Coenzyme Q10 and differences in coronary heart disease risk in Asian Indians and Chinese. FFCS Radic Biol Ned 32 (2):132-138. Published Material

Huntington Study Group, The. 2001. A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington’s disease. Neurology 57: 397-404. Published Material

Ibrahim, W.H.; Bhagavan, H.N.; Chopra, R.K.; Chow, C.K. 2000, Dietary coenzyme Q10 and vitamin E alter the status of these compounds in rat tissues and mitochondria. J Nutr 130 (9): 2343-2348. Published Material

Kaikkonen, J.; Nyyssonen, K.; Salonen, J.T. 1999. Measurement and stability of plasma reduced, oxidized and total coenzyme Q10 in humans. Stand J Clin Lab Invest 59: 457-466. Published Material

Kelso, G.F.; Porteous, C.M.; Hughes, G.; Ledgerwood, E.C.; Gane, A.M.; Smith, R.A.; Murphy, M.P. 2002. Prevention of mitochondrial oxidative damage using targeted antioxidants. Ann NY Acad Sci 959 (April): 263-274. Published Material

Kontush, A.; Schippling, S.; Spranger, 7.; Beisiegel, U. 1999. Plasma ubiquinol-10 as a marker for disease: is the assay worthwhile? BioFactors 9:225-229. Published Material

Kontush, A.; Reich, A.; Baum, K.; Spranger, T.; Finckh, 8.; KohlschGtter, A.; Beisiegel, U. 1997. Plasma ubiquind-10 is decreased in patients with hyperiipidaemia. Atherosclerosis 129: 119-126. Published Material

Lagendijk, J.; Ubbink, J.B.; Delport, R.; Vermaak, W.J.H.; Human, J.A. 1997. Ubiquinol/ubiquinone ratio as a marker of oxidative stress in coronary artery disease. Research Communications in Molecular Pathology and Pharmacology 95 (1): 11-20. Published Material

Lansjoen, P.H.; Langsjoen, P.H.; Fotkers, K. 1990. Long-term efficacy and safety of coenzyme Q10 therapy for idiopathic dilated cardiomyopathy. Am J Cardiol 65: 521-523. Published Material

Lass, A.; and Sohal, R.S. 1999. Comparisons of coenzyme Q bound to mitochondrial membrane proteins among different mammalian species. Free Radic Biol Med 27 (1-2) 220-226. Published Material

Lenaz, G. 2001. A critical appraisal of the mitochondrial coenzyme Q pool. FEBS Lett 509 (2): 151-155. Published Material

Matthews, R.T.; Yang, L.; Browns, S.; Baik, M.; Beal, M.F. 1998. Goenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc Natl Acad Sci USA 95 (15) :8892-8897. Published Material

Micromedex. Healthcare series. Ubidecarenone. Micromedex, inc., Englewood, CO. Cited in: Tran et al., 2001. Published Material

Miles, M.V.; Horn, P.S.; Morrison, J.A:; Tang, P.H.; DeGrauw, T.; Pesce, A.J. 2003. Plasma coenzyme Q10 reference intervals, but not redox status, are affected by gender and race in selfreported healthy adults, Clinica Chimica Acta 332: 123-132. Published Material

Mohr, D.; Bowry, V.W.; Stocker, R. 1992. Dietary supplementation with coenzyme Q10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low density lipoprotein to the initiation of lipid peroxidation. Biochim Biophys Acta 1126: 247-254. Published Material

Mugford, CA.; and Kedderis, G.L. 1998. Sex-dependent metabolism of xenobiotics. Drug Metab Rev 30 (3): 441-498. Published Material

Noack, H.; Kube, U.; Augustin, W. 1994. Relations between tocopherol depletion and coenzyme Q during lipid peroxidation in rat liver mitochondria. Free Radic. Res. 20: 375-386. Cited In: Ibrahim et al., 2000. Published Material

Nohl, H.; Kozlov, A.V.; Staniek, K.; Gifle, L. 2001. The multiple functions of coenzyme Q. Bioorg Chem 29 (1): 1-13. Published Material

Nohl, H.; Gille, L.; Staniek, K. 1998. The biochemical, pathophysiological, and medical aspects of ubiquinone function. Ann NY Acad Sci 854: 394-409. Published Material

Notake, Y., Tamura, S.; Toyoshima, S., Fujita, H., Suzuki, Y. and Chiba, T. 3972. Effects of coenzyme Q10 on development of the fetuses and neonates in rats and mice. Iyakuhin Kenkyu 3 (3): 306-315. Abstract in English. Also cited in Folkers and Morishita, 1987. Published Material

Okamoto, T.; Matsuya; T.; Fukunaga, Y.; Kishi, T.; Yamagami, T. 1989. Human serum ubiquinol-10 levels and relationship to serum lipids. Int J Vit Nutr Res 59: 288. Published Material

Pampori, N.A.; and Shapiro, B.H. 1999. Gender differences in the responsiveness of the sex-dependent isoforms of hepatic P450 to the feminine plasma growth hormone profile. Endocrinology 140 (3): 1245-1254. Published Material

Pepping, J. 1999. Coenzyme Q10. Am J Health Syst Pharm 56 (6): 519-521. Published Material

Podda, M.; Weber, C.; Traber, M.G.; .Packer, L. 1996. Simultaneous determination of tissue tocopherols, tocotrienols, ubiquinols, and ubiquinones, Journal of Lipid Research 37: 893-901. Published Material

Runquist, M.; Parmtyd, I.; Thelin, A.; Chojnacki, T.; Daliner, G. 1995. Distribution of branch point prenyltransferases in regions of bovine brain. J Neurochem 65: 2299-2306. Cited In: Turunen et al., 2004. Published Material

Schoepp, G. 1997. Is coenzyme Q10 (ubiquinone) effective for the treatment of heart failure? Pharmacy Practice (Canada) 13 (March): 31-32. Published Material

Schultz, J.R.; Ellerby, L.M.; Gralla, E.B.; Valentine, J.S.; Clarke, C.F. 1996. Autoxidation of ubiquinol-6 is independent of superoxide dismutase. Biochemistry 35: 6595. Cited In: Villalba et al., 2000. Published Material

Shapiro, B.H.; Agrawal; A.K,; Pampori, N.A. 1995. Gender differences in drug metabolism regulated by growth hormone. Int J Biochem Cell Biol 27 (1): 9-20. Published Material

Shults, C.W.; Oakes, D.; Kieburtz, K.; Beat, M.F.; Hass, R.; Plumb, S.; Juncos, J-L.; Nutt, J.; Shouison, I.; Carter, J.; Kompoliti, K.; Perlmutter, J.S.; Reich, S.; Stern, M.; Watts, R.L.; Kurlan, R.; Molho, E.; Harrison, M.; Lew, N. 2002. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. The Parkinson Study Group. Arch Neural 59 (10): 1541-1550. Abstract only. Published Material Published Material

Singh, RB.; Niaz, M.A.; Rastogi, V.; Rastogi, S.S. 1998. Coenzyme Q10 in cardiovascutar disease. JAPI 46 (3): 299-306. Published Material

Stocker, R.; and Frei, B. 1991. Endogenous antioxidant defenses in human blood plasma. In: sies, H. (Ed.). Oxidative Stress: Oxidants and Antioxidants. Academic Press, San Diego, pp. 213. Cited In: Villalba et al., 2000. Published Material

Stocker, R.; and Suarna, C. 1993. Extracellular reduction of ubiquinone-1 and -10 by human Hep G2 and blood ceils. Biochim Biophys Acta 1158: 15-22, Cited In: Kontush et al., 1999 and Villalba et al., 2000. Published Material

Takahashi, T.; Okamoto, T,; Mori, K.; Sayo, H.; Kishi, T. 1993. Distribution of ubiquinone and ubiquinol homologues in rat tissues and subcellular fractions. Lipids 28: 803-809. Published Material

Tang, P.H.; Miles, M.V.; Miles, L.; Quinlan, J.; Wong, B.; Wenisch, A,; Bove, K. 2004. Measurement of reduced and oxidized coenzyme Q9 and coenzyme Q10 levels in mouse tissues by HPLC with coulometric detection. Clinica Chimica Acta 341: 173-184. Published Material

Thomas, S.R.; Witting, P-K.; Stocker, R. 1999. A role for reduced coenzyme Q in atherosclerosis? BioFactors 9: 207-224. Published Material

Thomas, S.R.; Neuzil, J. ; Stocker, R. 1996. Co-supplementation with coenzyme Q prevents the pro-oxidant effect of a-tocopherol and increases the resistance of low-density lipoprotein towards transition metal-dependent oxidation initiation. Arterioscler Thromb Vast Biol 16: 687-696. Cited In: Thomas et al., 1999. Published Material

Tran, M.T.; Mitchell, T.M.; Kennedy, D.T.; Giles, J.T. 2001. Role of coenzyme Q10 in chronic heart failure, angina, and hypertension. Pharmacotherapy 21 (7): 797-806. Published Material

Turunen, M.; Olsson, J:; Dallner, G. 2004. Metabolism and function of coenzyme Q. Biochimica et Biophysics Acta 1660: 171-199. Published Material

Villalba, J.M.; Lopez-Lluch, G.; Santos-Ocana, C.; Rodriguez-Aguilera, J.C.; Navas, P. 2000. Extramitochondrial functions of coenzyme Q, In: Kagan, V-E. and.Quinn, P.J. (Eds.). Coenzyme Q: Molecular Mechanisms in Health and Disease. CRC Press, New York, pp. 83-98. Published Material

Weber, C.; Jakobsen, T.S.; Mortensen, S.A.; Paulsen, G.; Holmer, G. 1994. Effect of dietary coenzyme Q10 as an antioxidant in human plasma. Molec Aspects Med 15: s97-s102. Published Material

Williams, K.D., Maneke, J.D., AbdelHameed, M., Hall, R.L., Patmer, T.E., Kitano, M. and Hidaka, T. 1999. 52-Week oral gavage chronic toxicity study with ubiquinone in rats with a 4-week recovery. J Agric Food Chem 47: 3756-3763. Published Material

Wittenstein, B.; Klein, E.M.; Finckh, B.; Ullrich, K.; Kohlschutter, A. 2002. Plasma antioxidants in pediatric patients with glycogen storage disease, diabetes mellitus, and hypercholesterolemia. Free Radical Biology & Medicine 33 (1): 103-110. Published Material

Yamamoto, Y.; and Yamashita, S. 1999. Piasma ubiquinone,to ubiquinol ratio in patients with hepatitis, cirrhosis, and hepatoma, and in patients treated with percutaneous transluminal coronary reperfusion. Molec Aspects Med 18 (Supplement): s79-s84. Published Material

Yamamoto, Y.; and Yamashita, S. 1997. Plasma ratio of ubiquinol and ubiquinone as a marker of oxidative stress. Molec Aspects Med 18 (Supplement): s79-s84. Published Material

Yamashita, S.; and Yamamoto, Y. 1997. Simultaneous detection of ubiquinol and ubiquinone in human plasma as a marker of oxidative stress. Anal Biochem 250: 66-73. Published Material


Top | Back

Page last updated June 7, 2005 RSChorizonal rule
Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management